Unicycive Therapeutics (NASDAQ:UNCY) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Unicycive Therapeutics (NASDAQ:UNCY – Free Report) from a sell rating to a hold rating in a research report released on Saturday. Separately, HC Wainwright raised Unicycive Therapeutics to a “strong-buy” rating and set a $90.00 target price on the stock in a report on Tuesday, May 27th. One equities […]
2 Sep 01:28 · The Cerbat Gem